CN Patent

CN109897004A — 恩杂鲁胺制剂

Assigned to Astellas Pharma Inc · Expires 2019-06-18 · 7y expired

What this patent protects

本发明提供恩杂鲁胺制剂及其治疗过度增殖性疾病的用途。

USPTO Abstract

本发明提供恩杂鲁胺制剂及其治疗过度增殖性疾病的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN109897004A
Jurisdiction
CN
Classification
—
Expires
2019-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Astellas Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.